125 ambien cr Its lead product, LIPOFENŽ (fenofibrate capsules), is indicated as adjunctive therapy to diet to reduce elevated triglycerides and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia.kowapharma. R&D activities are carried out directly or under contract. announced today that the U. The Complete Response Letter raises issues regarding the potential abuse deterrent benefits of Acurox.
.
News
"
KPA obtained exclusive U.
About Applied Pharma Research
APR Applied Pharma Research SA is an independent, international, vertically integrated drug delivery and drug development company in healthcare with registered offices in Switzerland and the U. announced today that the U.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements..